A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J.S. Chen(Chang Gung University), Chih‐Hung Hsu(National Taiwan University Hospital), Nai‐Jung Chiang(Kaohsiung Medical University), Chung-Ming Tsai(Tainan Municipal Hospital), Hsiao‐Hui Tsou(National Health Research Institutes), Shiu-Feng Huang(National Health Research Institutes), Li‐Yuan Bai(China Medical University), I.‐C. Chang(National Health Research Institutes), H. Shiah(Taipei Medical University Hospital), Ching‐Liang Ho(Tri-Service General Hospital), Chung‐Jen Yen(National Cheng Kung University Hospital), K.D. Lee(Chiayi Chang Gung Memorial Hospital), C.-F. Chiu(China Medical University), K.-M. Rau(Kaohsiung Chang Gung Memorial Hospital), Ming‐Sun Yu(Kaohsiung Veterans General Hospital), Youngsen Yang(Taichung Veterans General Hospital), Ruey‐Kuen Hsieh(Mackay Memorial Hospital), Jang‐Yang Chang(National Health Research Institutes), Yan‐Shen Shan(National Cheng Kung University Hospital), Yee Chao(Taipei Veterans General Hospital), Liang-Yi Chen(Kaohsiung Medical University), Wen‐Chi Shen, Hung‐Chih Hsu(National Taiwan University Hospital), Chih‐Hung Hsu(National Taiwan University), Ying‐Chun Shen, Tsang-En Wang, Chung‐Pin Li, Ming‐Huang Chen(Kaohsiung Medical University), Wei-Yao Kao, Ping‐Ying Chang(National Health Research Institutes), Cheng-Chung Wu, Chien-Lin Teng, Chang‐Hsien Lu, Shyh‐Jer Lin, Being‐Whey Wang, Yen‐Yang Chen(Kaohsiung Medical University), Yung-Hsin Chin, Tsai-Rong Chung, Wei-Lan Yu(Kaohsiung Veterans General Hospital), Mei-Hua Lee(Chiayi Chang Gung Memorial Hospital), Ling-Fang Lin, Pei-Chyi Lin, Yaling Wu, Huiling Wang, LU Li-ju, Shiang-Yi Chen(Kaohsiung Medical University), Chih-Chu Wu, Te-Chih Wei
Cited by 158
Abstract
Related Papers
No related papers found
Powered by citation graph analysis